NO961995D0 - Anvendelse av IGF-BP for renaturering av IGF - Google Patents

Anvendelse av IGF-BP for renaturering av IGF

Info

Publication number
NO961995D0
NO961995D0 NO961995A NO961995A NO961995D0 NO 961995 D0 NO961995 D0 NO 961995D0 NO 961995 A NO961995 A NO 961995A NO 961995 A NO961995 A NO 961995A NO 961995 D0 NO961995 D0 NO 961995D0
Authority
NO
Norway
Prior art keywords
igf
pct
date
insulin
sec
Prior art date
Application number
NO961995A
Other languages
English (en)
Other versions
NO961995L (no
Inventor
Bjorn Nilsson
Sophia Elisabeth Hober
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of NO961995D0 publication Critical patent/NO961995D0/no
Publication of NO961995L publication Critical patent/NO961995L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO961995A 1993-11-16 1996-05-15 Anvendelse av IGF-BP for renaturering av IGF NO961995L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303784A SE9303784D0 (sv) 1993-11-16 1993-11-16 Igf
PCT/SE1994/001076 WO1995014034A1 (en) 1993-11-16 1994-11-14 Use of igf-bp for refolding of igf

Publications (2)

Publication Number Publication Date
NO961995D0 true NO961995D0 (no) 1996-05-15
NO961995L NO961995L (no) 1996-05-15

Family

ID=20391767

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961995A NO961995L (no) 1993-11-16 1996-05-15 Anvendelse av IGF-BP for renaturering av IGF

Country Status (12)

Country Link
US (1) US5683980A (no)
EP (1) EP0736040B1 (no)
JP (1) JP3609410B2 (no)
AT (1) ATE190627T1 (no)
AU (1) AU684117B2 (no)
CA (1) CA2176599A1 (no)
DE (1) DE69423516T2 (no)
FI (1) FI962081L (no)
NO (1) NO961995L (no)
NZ (1) NZ276520A (no)
SE (1) SE9303784D0 (no)
WO (1) WO1995014034A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789547A (en) * 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
US6417330B1 (en) 1998-06-01 2002-07-09 Celtrix Pharmaceuticals, Inc. Insulin-like growth factor binding protein variants
JP3734634B2 (ja) * 1999-03-03 2006-01-11 ヒゲタ醤油株式会社 タンパク質の活性化方法及び該装置
KR20020074749A (ko) * 2001-03-21 2002-10-04 한국생명공학연구원 재조합 인슐린 유사성장인자-1의 대량 생산방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8826451D0 (en) * 1988-11-11 1988-12-14 Sandoz Ltd Improvements in/relating to organic compounds
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
WO1992014834A1 (en) * 1991-02-14 1992-09-03 The Whittier Institute For Diabetes And Endocrinology Insulin-like growth factor binding protein
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
WO1993019084A1 (en) * 1992-03-24 1993-09-30 Synergen, Inc. Refolding and purification of insulin-like growth factor i
US5407913A (en) * 1992-12-03 1995-04-18 Celtrix Pharmaceuticals, Inc. Method and composition for systemic treatment of tissue injury

Also Published As

Publication number Publication date
CA2176599A1 (en) 1995-05-26
AU1080895A (en) 1995-06-06
NZ276520A (en) 1997-11-24
DE69423516D1 (de) 2000-04-20
WO1995014034A1 (en) 1995-05-26
DE69423516T2 (de) 2000-09-14
FI962081A0 (fi) 1996-05-15
FI962081A7 (fi) 1996-07-15
JPH09505077A (ja) 1997-05-20
ATE190627T1 (de) 2000-04-15
US5683980A (en) 1997-11-04
EP0736040B1 (en) 2000-03-15
EP0736040A1 (en) 1996-10-09
SE9303784D0 (sv) 1993-11-16
AU684117B2 (en) 1997-12-04
JP3609410B2 (ja) 2005-01-12
NO961995L (no) 1996-05-15
FI962081L (fi) 1996-07-15

Similar Documents

Publication Publication Date Title
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
DK0575443T3 (da) Ærteproteinhydrolysat, fremgangsmåde til dets fremstilling og anvendelse deraf
DK0749478T3 (da) Gærstammer og modificerede albuminer
ATE81779T1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
DE69130506D1 (de) Nukleotidsequenzen kodierend für ein humanes protein mit angiogenetisch-regulatorischen eigenschaften
AU1955388A (en) Method for potentiating and inhibiting insulin-like growth factor activity
ATE389416T1 (de) Behandlung von knorpelerkrankungen
DE69228749D1 (de) Neuartige polypeptide und ihre verwendung
ATE339878T1 (de) Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
ATE301714T1 (de) Insulinartigen wachstumsfaktor bindendes protein -3 variante
ATE183397T1 (de) Behandlung präkanzeröser läsionen durch muramylpeptide
NO961995D0 (no) Anvendelse av IGF-BP for renaturering av IGF
CO4700528A1 (es) Peptidos de somatostatina
ATE243712T1 (de) Vekürztes insulinähnlichen wachstumsfaktor- bindendes protein mit mitogener aktivität
ATE165619T1 (de) Rekombinante antikörper an der oberfläche von e.coli
DK0561877T3 (da) Forbindelser og præparater der hæmmer knogleresorption
NO970113L (no) Kollagenbindende protein eller polypeptid
AU6750990A (en) A protein purification method
GB2262528B (en) Further improvements relating to the radiolabelling of proteins
SE9303068D0 (sv) New use
CA2074182A1 (en) Process for the reactivation of denatured protein
ATE121422T1 (de) Neue antikoagulatorisch wirksame peptide.
SE8501202D0 (sv) Human intestinal hormone and its use
MX9205978A (es) Nuevas proteinas inhibidoras de trombina de garrapatas.
EP0723016A3 (en) Leukocyte activation factor